Physician profile
Erek W Latzka
NPI 1336587385
$1,122.29
in general payments reported to CMS, 2019-2025
10 companies · $469 in 2025
The $469 reported for 2025 was more than what 85% of Sports Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $192 · 2024: $461 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $386.10 | 2023-2025 | Sx-One Microknife |
| Trice Medical, INC. | $186.28 | 2024 | |
| Ge Healthcare | $184.02 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $128.15 | 2025 | |
| Zimmer Biomet Holdings, INC. | $112.07 | 2023-2025 | Bma Kit, Gel-One Cross-Linked Hyaluronate |
| Abbvie INC. | $33.27 | 2024 | |
| Depuy Synthes Sales INC. | $31.78 | 2024 | Monovisc, Orthovisc |
| Pacira Pharmaceuticals Incorporated | $21.24 | 2023 | Zilretta, Iovera |
| Bioventus LLC | $19.94 | 2024 | Durolane |
| Ferring Pharmaceuticals INC. | $19.44 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erek Latzka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.